| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated Phase CML: Outcomes in Newly Diagnosed vs. Progression From Chronic Phase
|
Mukherjee, Sudipto
|
|
2016
|
11 |
2 |
p. 86-93
|
artikel
|
| 2 |
Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents
|
Nathwani, Nitya
|
|
2016
|
11 |
2 |
p. 127-136
|
artikel
|
| 3 |
Diagnostic Advances in Multiple Myeloma
|
Barley, Kevin
|
|
2016
|
11 |
2 |
p. 111-117
|
artikel
|
| 4 |
Long-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
|
Caldemeyer, Lauren
|
|
2016
|
11 |
2 |
p. 71-79
|
artikel
|
| 5 |
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
|
Nishihori, Taiga
|
|
2016
|
11 |
2 |
p. 118-126
|
artikel
|
| 6 |
New Methodologies in the Molecular Monitoring of CML
|
Yeung, Cecilia C. S.
|
|
2016
|
11 |
2 |
p. 94-101
|
artikel
|
| 7 |
Practical Approaches to the Management of Dual Refractory Multiple Myeloma
|
Lee, Hans C.
|
|
2016
|
11 |
2 |
p. 148-155
|
artikel
|
| 8 |
Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia
|
Flynn, Kathryn E.
|
|
2016
|
11 |
2 |
p. 80-85
|
artikel
|
| 9 |
Risk Stratification in Multiple Myeloma
|
Ooi, Melissa Gaik-Ming
|
|
2016
|
11 |
2 |
p. 137-147
|
artikel
|
| 10 |
Signaling Pathways and Emerging Therapies in Multiple Myeloma
|
Ramakrishnan, Vijay
|
|
2016
|
11 |
2 |
p. 156-164
|
artikel
|
| 11 |
Smoldering Multiple Myeloma: Emerging Concepts and Therapeutics
|
Sundararajan, Srinath
|
|
2016
|
11 |
2 |
p. 102-110
|
artikel
|
Tijdschrift beschrijving